Latest Updates

Lupin to market Linagliptin for Boehringer Ingelheim under the brand name Ondero and Ondero Met in India Lupin and Boehringer…

Drug modification technology platform can help address sub-optimal physico-chemical and pharmacokinetic properties of approved…

Based on the recommendations of the Expert Appraisal Committee (EAC), the ministry gave final green nod to the 'A' category…

DRL will be permitted to market a 505(j) generic version of Aloxi in the US on September 30, 2018 or earlier under certain…

Future heparin incident may lead to a backlash against outsourcing and drug shortages

Sets up office in Bengaluru Indonesia-based herbal skin care products company has announced its entry into the Indian market. The…

There are apprehensions that takeovers by MNCs have impacted the generic medicine industry of the country The government is…

New personalised medicines offer increased survival benefit and improved quality of life to Indian women with aggressive…

Supports the ‘Make in India’ campaign for the benefit of the Indian healthcare sector

DoP's Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) prohibits companies from supplying drugs as samples…